Business Standard

Small contract manufacturers wait to take a shot at Covid vaccines

A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors

coronavirus, vaccine, vaccination, covid-19
Premium

India, which accounts for 60 per cent of the world’s vaccine production (by volume) and supplies 60-80% of the UN’s annual vaccine procurement, has been ramping up its vaccine capacity since 2020

Sohini Das &Vinay Umarji Mumbai/Ahmedabad
As India, the world’s vaccine factory, gears up to produce more Covid-19 vaccines — both indigenous and foreign — the stage is set for the smaller contract manufacturers to step in. Foreign vaccines such as Moderna and Pfizer-BioNTech’s mRNA vaccines are expected to enter India, but the government has indicated that it would expect that these vaccines would be eventually manufactured here.

Does India have the capacit­i­es and the expertise to make these vaccines based on new technology?

“India has enough fill and finish capacities, and there are several players such as Indian Immunologicals or even Lupin, which have evinced

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in